| Caption | CEO Dr. William CAO gave speech of FasT CAR technology on the CAR-TCR Summit Boston. |
| Source | Gracell |
| Download | |
| Related Press Releases Links |
Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs 亘喜生物公布全球首创FasT CAR-19细胞治疗复发或难治急性 B 淋巴细胞白血病 (B-ALL) 的中期研究结果，并将FasT CAR技术应用在其它免疫细胞治疗项目 |